Adma Biologics (ADMA) Shareholder's Equity Growth (3y) (2014 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn |
| 10 | Adma Biologics | 1.90 Bn | 1.81 Bn | 88.82 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 46.45% |
| Sep 30, 2025 | 62.55% |
| Jun 30, 2025 | 51.57% |
| Mar 31, 2025 | 43.29% |
| Dec 31, 2024 | 35.22% |
| Sep 30, 2024 | 31.16% |
| Jun 30, 2024 | 19.05% |
| Mar 31, 2024 | 10.96% |
| Dec 31, 2023 | 15.28% |
| Sep 30, 2023 | 28.50% |
| Jun 30, 2023 | 24.05% |
| Mar 31, 2023 | 14.77% |
| Dec 31, 2022 | 79.69% |
| Sep 30, 2022 | 40.60% |
| Jun 30, 2022 | 34.61% |
| Mar 31, 2022 | 132.97% |
| Dec 31, 2021 | 92.57% |
| Sep 30, 2021 | 40.31% |
| Jun 30, 2021 | 29.19% |
| Mar 31, 2021 | 69.69% |
| Dec 31, 2020 | 29.82% |
| Sep 30, 2020 | 76.45% |
| Jun 30, 2020 | 40.56% |
| Mar 31, 2020 | 122.09% |
| Dec 31, 2019 | 98.97% |
| Dec 31, 2018 | 188.78% |
| Dec 31, 2017 | 88.64% |
| Dec 31, 2015 | -55.67% |
| Dec 31, 2014 | 149.73% |